Clinical Trial Update: A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

AstraZeneca is evaluating AZD0486 as a monotherapy or in combination with other anticancer agents for mature B-cell malignancies in Phase 1/2 trials that are cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• AZD0486 (AZD0486)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma | Phase 1, Phase 2 | Status: RECRUITING